Significantly, a genetic variation in the SLC6A3 gene (encoding DAT) has been associated with disulfiram treatment for cocaine addiction, with patients with higher DAT levels having better treatment outcomes than those with lower DAT levels [65]. Here, SLC6A3 is linked to cocaine dependence.